By Stephanie Brown HealthDay ReporterMONDAY, Aug. 4, 2025 (HealthDay News) -- The U.S. Food and Drug Administration announced ...

In a significant move aimed at combating the ongoing opioid epidemic, the U.S. Food and Drug Administration (FDA) has announced major ...

Federal officials plan to send warning letters to companies marketing products with 7-OH, part of effort to fight America's ...

The FDA is requiring opioid pain medication manufacturers to update safety labeling with a stronger emphasis on risks from long-term use, including addiction and overdose death.

The Food and Drug Administration (FDA) is requiring class-wide label changes for opioid medications to provide additional information on the risks associated with long-term use.

The FDA is mandating labeling changes for opioid pain medications to highlight the risks associated with their prolonged use. In May, members of a public advisory committee examined data linking ...

Republican lawmakers on the committee, who nearly unanimously voted against the measure, voiced concern about the centers’ ...

The City Council's Public Safety Committee heard about opioid trends and potential solutions to the drug crisis during a ...

Launched in July 2024, a north shore drug task force has seen a growing collaboration among law enforcement agencies and an ...

Today, the Glasgow Police Department received Opioid Overdose Kits from the Barren County Health Department. Each officer was ...

Cheryl Juaire, a mother from Marlborough, has fulfilled her mission in honor of her two late sons by creating opioid overdose ...

The continued risk posed by the local illegal drug supply motivated the Windsor Police Service to put out a community alert ...